文献速递肝病消化道肿瘤与早癌

B细胞在NAFLD发病机制中的新兴作用

The Emerging Role of B Cells in the Pathogenesis of NAFLD.
PubMed 文献 · Hepatology · 2021-06-18

本文综述了肝内B细胞在NAFLD进展中的新兴证据,探讨了B细胞激活的潜在机制,包括肝脏B细胞激活因子表达增加、氧化应激增强和肠道微生物产物易位,并讨论了B细胞通过产生促炎细胞因子和调节肝内T细胞与巨噬细胞促进NAFLD的可能效应功能,最后强调了调节性B细胞和IgA+ B细胞在NASH相关HCC中的作用。

要点

  • 肝内B细胞可能参与NAFLD进展
  • B细胞激活机制包括BAFF表达增加、氧化应激和微生物产物易位
  • B细胞通过促炎细胞因子和调节T细胞/巨噬细胞发挥效应

核心结论

  • B细胞在NAFLD和NASH发病机制中可能发挥重要作用,未来需研究B细胞靶向治疗策略。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • 肝内B细胞参与NAFLD进展的证据 emerging。
  • NAFLD中B细胞激活的潜在机制包括肝脏B细胞激活因子表达增加、氧化应激增强和肠道微生物产物易位。
  • B细胞可能通过产生促炎细胞因子和调节肝内T细胞与巨噬细胞促进NAFLD。
  • 调节性B细胞和IgA+ B细胞在NASH相关HCC中发挥作用。

临床怎么用

  • 当前证据尚不支持B细胞靶向策略常规用于NAFLD治疗,需进一步研究。

局限性

  • 本文为综述,未报告原始研究数据;B细胞在NAFLD中的作用尚不明确,需未来研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

NAFLD is one of the leading causes of abnormal liver function worldwide. NAFLD refers to a group of liver conditions ranging from nonalcoholic fatty liver to NASH, which involves inflammation, hepatocellular damage, and fibrosis. Triggering of inflammation in NASH is a key event in the progression of the disease, and identifying the factors that initiate or dysregulate this process is needed to develop strategies for its prevention or treatment. B cells have been implicated in several autoimmune and inflammatory diseases. However, their role in the pathogenesis of NAFLD and NASH is less clear. This review discusses the emerging evidence implicating intrahepatic B cells in the progression of NAFLD. We highlight the potential mechanisms of B-cell activation during NAFLD, such as increased hepatic expression of B-cell-activating factor, augmented oxidative stress, and translocation of gut-derived microbial products. We discuss the possible effector functions by which B cells promote NAFLD, including the production of proinflammatory cytokines and regulation of intrahepatic T cells and macrophages. Finally, we highlight the role of regulatory and IgA+ B cells in the pathogenesis of NASH-associated HCC. In this review, we make the case that future research is needed to investigate the potential of B-cell-targeting strategies for the treatment of NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Barrow F, Khan S, Wang H, et al. The Emerging Role of B Cells in the Pathogenesis of NAFLD. Hepatology. 2021. PMID: 33961302. doi:10.1002/hep.31889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。